Feasibility of mobile cancer screening and prevention

被引:12
|
作者
O'Malley, AS [1 ]
Lawrence, W
Liang, WC
Yabroff, R
Lynn, J
Kerner, J
Mandelblatt, J
机构
[1] Georgetown Univ, Med Ctr, Canc Control Progran, Lombardi Canc Ctr, Washington, DC 20007 USA
[2] Georgetown Univ, Med Ctr, Dept Surg, Washington, DC 20007 USA
[3] NCI, Div Canc Control & Pop Sci, NIH, Bethesda, MD 20892 USA
关键词
underserved; cancer/prevention and control; screening; mobile mammography;
D O I
10.1177/10408902013003004
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Many areas have high cancer mortality rates and medically underserved populations. This study describes the feasibility (acceptability and costs) of an urban multiphasic (multiple cancers) screening van. Feasibility was evaluated by literature review and informant interviews. Costs were estimated by resource use from urban mobile screening units; decision analysis estimated the costs per cancer detected for breast, cervix, colorectal, and prostate cancer screening. Acceptability of a multiphasic van varied by the informant's perspective. Feasibility and costs were most sensitive to four parameters: age, prior screening history, risk factors, and volume of simultaneous examinations. Subsidized mobile screening facilities may have the potential to reduce cancer morbidity and mortality if they target hard-to-reach underscreened groups, maintain high volume, coordinate with primary care providers, and build on all infrastructure that provides diagnostic and treatment services regardless of ability to pay. It is unclear whether the investment required will translate into a reasonable cost per year of life saved.
引用
收藏
页码:298 / 319
页数:22
相关论文
共 50 条
  • [41] Innovation and equity in cancer prevention and screening
    Lowy, Douglas R.
    CANCER PREVENTION RESEARCH, 2023, 16 (01)
  • [42] Prevention, screening and management of colon cancer
    Faivre, J
    Adenis, A
    Bretagne, JF
    Carpentier, F
    Durocher, A
    Debeco, I
    Fournet, J
    Gignoux, M
    Guyot, P
    Legoux, JL
    Meyer, C
    Papazian, A
    Pienkowski, P
    Potet, F
    Sancho-Garnier, H
    Seitz, JF
    Arnaud, JP
    Audigier, JC
    Cassigneul, J
    Conroy, T
    De Saint-Louvent, P
    Esteve, J
    L'Hermine, C
    Lasser, P
    Magnier, AM
    Mandard, AM
    Mantz, JM
    Pillon, D
    Roy, P
    Rusz-Niewski, M
    Salle, E
    Souweine, G
    Arveux, P
    Bedenne, L
    Benamouzig, R
    Benhamiche, AM
    Berard, P
    Boutron-Ruault, MC
    Boyer, J
    Canard, JM
    Delpero, JR
    Diebold, MD
    Dorval, ED
    Ducreux, M
    Grosclaude, P
    Jaeck, D
    Kronborg, O
    Launoy, G
    Lefebvre, R
    Lehur, PA
    SEMAINE DES HOPITAUX, 1998, 74 (15-16): : 709 - 717
  • [43] Cytological screening for cervical cancer prevention
    Denny, Lynette
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2012, 26 (02) : 189 - 196
  • [44] Notes on breast cancer prevention and screening
    Koest, Hans-Peter
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2015, 8 (03) : 198 - 200
  • [45] Cancer screening: A modest proposal for prevention
    Kim, Myung S.
    Nishikawa, Go
    Prasad, Vinay
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2019, 86 (03) : 157 - 160
  • [46] Breast cancer risk: Screening and prevention
    Crowe, JP
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 187 (04) : 454 - 455
  • [47] Colorectal cancer screening: for prevention or cure?
    Fletcher, Robert H.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2009, 63 (07) : 505 - 506
  • [48] Screening, Surveillance, and Prevention for Esophageal Cancer
    Tomizawa, Yutaka
    Wang, Kenneth K.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2009, 38 (01) : 59 - +
  • [49] Cervical cancer Screening, management, and prevention
    Wuerthner, Barbara A.
    Avila-Wallace, Maria
    NURSE PRACTITIONER, 2016, 41 (09): : 18 - 23
  • [50] Screening and Prevention Methods for Cervical Cancer
    Schiffman, Mark
    Solomon, Diane
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (16): : 1809 - 1810